Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 20/20 | 0.84 |
| ▸ | EDNRB | P24530 | 12/20 | 0.70 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.66 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.66 |
| ▸ | PDE4A | P27815 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4631877 | 0.93 | EDNRA (0.84) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL13324177 | 0.93 | EDNRA (0.86) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL4661728 | 0.91 | EDNRA (0.81) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL4632015 | 0.91 | EDNRA (0.81) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL802427 | 0.91 | EDNRA (1.00) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL6971496 | 0.91 | EDNRA (0.75) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL4630642 | 0.90 | EDNRA (0.79) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL4631364 | 0.90 | EDNRA (0.81) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL4631411 | 0.89 | EDNRA (0.81) | EDNRAEDNRBABCC3ABCC4ABCB11 | |
| SCHEMBL7961933 | 0.89 | EDNRA (0.81) | EDNRAEDNRBABCC3ABCC4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0819125-B1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORP (US) | 2003-06-18 | — | — | EP | claimed |
| CN-1184470-A | Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORP (US) | 1998-06-10 | — | — | CN | claimed |
| CN-1636994-B | Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby | ENCYSIVE PHARMACEUTICALS INC | 2010-05-12 | — | — | CN | disclosed |
| CN-1636994-A | Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby | ENCYSIVE PHARMACEUTICALS INC (US) | 2005-07-13 | — | — | CN | disclosed |
| CN-1179961-C | Sulfonamides for the treatment of endothelin mediated diseases | ��ɪϣ����ҩ��˾ | 2004-12-15 | — | — | CN | disclosed |